B. Guthrie

First name
B.
Last name
Guthrie
Mok, P. L. H., Carr, M. J., Guthrie, B., Morales, D. R., Sheikh, A., Elliott, R. A., et al. (2024). Multiple adverse outcomes associated with antipsychotic use in people with dementia: population based matched cohort study. Bmj, 385, e076268. http://doi.org/10.1136/bmj-2023-076268
View
Guthrie, B., Rogers, G., Livingstone, S., Morales, D. R., Donnan, P., Davis, S., et al. (2024). The implications of competing risks and direct treatment disutility in cardiovascular disease and osteoporotic fracture: risk prediction and cost effectiveness analysis. Health Soc Care Deliv Res, 12, 1-275. http://doi.org/10.3310/kltr7714
View
Livingstone, S., Morales, D. R., Fleuriot, J., Donnan, P. T., & Guthrie, B. (2023). External validation of the QLifetime cardiovascular risk prediction tool: population cohort study. Bmc Cardiovasc Disord, 23, 194. http://doi.org/10.1186/s12872-023-03209-8
View
Livingstone, S. J., Morales, D. R., McMinn, M., Eke, C., Donnan, P., & Guthrie, B. (2022). Effect of competing mortality risks on predictive performance of the QFracture risk prediction tool for major osteoporotic fracture and hip fracture: external validation cohort study in a UK primary care population. Bmj Med, 1, e000316. http://doi.org/10.1136/bmjmed-2022-000316
View
Livingstone, S. J., Guthrie, B., McMinn, M., Eke, C., Donnan, P. T., & Morales, D. R. (2023). Derivation and validation of the CFracture competing risk fracture prediction tool compared with QFracture in older people and people with comorbidity: a population cohort study. Lancet Healthy Longev, 4, e43-e53. http://doi.org/10.1016/s2666-7568(22)00290-2
View
Livingstone, S. J., Guthrie, B., Donnan, P. T., Thompson, A., & Morales, D. R. (2022). Predictive performance of a competing risk cardiovascular prediction tool CRISK compared to QRISK3 in older people and those with comorbidity: population cohort study. Bmc Med, 20, 152. http://doi.org/10.1186/s12916-022-02349-6
View
Morales, D. R., Dreischulte, T., Lipworth, B. J., Donnan, P. T., Jackson, C., & Guthrie, B. (2016). Respiratory effect of beta-blocker eye drops in asthma: population-based study and meta-analysis of clinical trials. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.13006
View
Kontopantelis, E., Springate, D. A., Ashcroft, D. M., Valderas, J. M., van der Veer, S. N., Reeves, D., et al. (2016). Associations between exemption and survival outcomes in the UK\textquoterights primary care pay-for-performance programme: a retrospective cohort study. BMJ Qual Saf. http://doi.org/10.1136/bmjqs-2015-004602
View
Morales, D. R., Lipworth, B. J., Donnan, P. T., Jackson, C., & Guthrie, B. (2017). Respiratory effect of beta-blockers in people with asthma and cardiovascular disease: population-based nested case control study. BMC Med. http://doi.org/10.1186/s12916-017-0781-0
View
Livingstone, S., Morales, D. R., Donnan, P. T., Payne, K., Thompson, A. J., Youn, J. H., & Guthrie, B. (2021). Effect of competing mortality risks on predictive performance of the QRISK3 cardiovascular risk prediction tool in older people and those with comorbidity: external validation population cohort study. Lancet Healthy Longev. http://doi.org/10.1016/s2666-7568(21)00088-x
View